As shown in Figure 1D,H, a significant difference in promoter methylation level of CYP24A1, which was quantified by averaging the methylation levels of all three significant CpG sites, was observed between tumor tissues and adjacent normal tissues in both GSE48684 and GSE193535 datasets (p < 0.05). Here, CYP24A1 is linked to neoplasm.